Aadi Bioscience, Inc. (AADI) Stock Analysis
DELISTED 2025
What happened to Aadi Bioscience, Inc. (AADI) stock?
Aadi Bioscience, Inc. (AADI) no longer trades on public markets. It was delisted in March 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2025
- Last recorded price (historical):
- $2.05 (last quote on record before the March 2025 delisting; historical, not a current quote)
Market cap $94.9M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Aadi Bioscience, Inc. (AADI). Aadi Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on developing precision therapies for genetically defined cancers. Its lead drug candidate, FYARRO, targets cancers with mTOR pathway gene alterations, including tumor-agnostic indications.
Last analyzed: Jun 15, 2026Aadi Bioscience, Inc. (AADI) Healthcare & Pipeline Overview
More about this archive record
Can I still buy AADI shares?
No. AADI stopped trading on public markets in March 2025, so the shares are not available through a broker. Anything you see quoted for AADI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AADI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Aadi Bioscience, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.